Literature DB >> 18722178

Genome-wide analysis of the H3K4 histone demethylase RBP2 reveals a transcriptional program controlling differentiation.

Nuria Lopez-Bigas1, Tomasz A Kisiel1, Dannielle C DeWaal2, Katie B Holmes2, Tom L Volkert3, Sumeet Gupta3, Jennifer Love3, Heather L Murray3, Richard A Young3, Elizaveta V Benevolenskaya4.   

Abstract

Retinoblastoma protein (pRB) mediates cell-cycle withdrawal and differentiation by interacting with a variety of proteins. RB-Binding Protein 2 (RBP2) has been shown to be a key effector. We sought to determine transcriptional regulation by RBP2 genome-wide by using location analysis and gene expression profiling experiments. We describe that RBP2 shows high correlation with the presence of H3K4me3 and its target genes are separated into two functionally distinct classes: differentiation-independent and differentiation-dependent genes. The former class is enriched by genes that encode mitochondrial proteins, while the latter is represented by cell-cycle genes. We demonstrate the role of RBP2 in mitochondrial biogenesis, which involves regulation of H3K4me3-modified nucleosomes. Analysis of expression changes upon RBP2 depletion depicted genes with a signature of differentiation control, analogous to the changes seen upon reintroduction of pRB. We conclude that, during differentiation, RBP2 exerts inhibitory effects on multiple genes through direct interaction with their promoters.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18722178      PMCID: PMC3003864          DOI: 10.1016/j.molcel.2008.08.004

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  42 in total

1.  Control of pancreas and liver gene expression by HNF transcription factors.

Authors:  Duncan T Odom; Nora Zizlsperger; D Benjamin Gordon; George W Bell; Nicola J Rinaldi; Heather L Murray; Tom L Volkert; Jörg Schreiber; P Alexander Rolfe; David K Gifford; Ernest Fraenkel; Graeme I Bell; Richard A Young
Journal:  Science       Date:  2004-02-27       Impact factor: 47.728

Review 2.  The E2F transcriptional network: old acquaintances with new faces.

Authors:  Desssislava K Dimova; Nicholas J Dyson
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

3.  Altered expression of the retinoblastoma tumor-suppressor gene in leukemic cell lines inhibits induction of differentiation but not G1-accumulation.

Authors:  G Bergh; M Ehinger; T Olofsson; B Baldetorp; E Johnsson; H Brycke; G Lindgren; I Olsson; U Gullberg
Journal:  Blood       Date:  1997-04-15       Impact factor: 22.113

4.  Induction of differentiation in human promyelocytic leukemia cells by tumor promoters.

Authors:  G Rovera; T G O'Brien; L Diamond
Journal:  Science       Date:  1979-05-25       Impact factor: 47.728

5.  The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system.

Authors:  Sara Pich; Daniel Bach; Paz Briones; Marc Liesa; Marta Camps; Xavier Testar; Manuel Palacín; Antonio Zorzano
Journal:  Hum Mol Genet       Date:  2005-04-13       Impact factor: 6.150

6.  T-cell oncogene rhombotin-2 interacts with retinoblastoma-binding protein 2.

Authors:  S Mao; G A Neale; R M Goorha
Journal:  Oncogene       Date:  1997-04-03       Impact factor: 9.867

7.  Dysregulation of HSG triggers vascular proliferative disorders.

Authors:  Kuang-Hueih Chen; Xiaomei Guo; Dalong Ma; Yanhong Guo; Qian Li; Dongmei Yang; Pengfei Li; Xiaoyan Qiu; Shaojun Wen; Rui-Ping Xiao; Jian Tang
Journal:  Nat Cell Biol       Date:  2004-08-22       Impact factor: 28.824

8.  Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein.

Authors:  Y W Kim; G A Otterson; R A Kratzke; A B Coxon; F J Kaye
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

9.  Characterization of the retinoblastoma binding proteins RBP1 and RBP2.

Authors:  A R Fattaey; K Helin; M S Dembski; N Dyson; E Harlow; G A Vuocolo; M G Hanobik; K M Haskell; A Oliff; D Defeo-Jones
Journal:  Oncogene       Date:  1993-11       Impact factor: 9.867

10.  Human PLU-1 Has transcriptional repression properties and interacts with the developmental transcription factors BF-1 and PAX9.

Authors:  Keith Tan; Anthony L Shaw; Bente Madsen; Kirsten Jensen; Joyce Taylor-Papadimitriou; Paul S Freemont
Journal:  J Biol Chem       Date:  2003-03-25       Impact factor: 5.157

View more
  80 in total

1.  Histone demethylase KDM5A is an integral part of the core Notch-RBP-J repressor complex.

Authors:  Robert Liefke; Franz Oswald; Cristobal Alvarado; Dolores Ferres-Marco; Gerhard Mittler; Patrick Rodriguez; Maria Dominguez; Tilman Borggrefe
Journal:  Genes Dev       Date:  2010-03-15       Impact factor: 11.361

2.  Mitochondrial Citrate Transporter-dependent Metabolic Signature in the 22q11.2 Deletion Syndrome.

Authors:  Eleonora Napoli; Flora Tassone; Sarah Wong; Kathleen Angkustsiri; Tony J Simon; Gyu Song; Cecilia Giulivi
Journal:  J Biol Chem       Date:  2015-07-28       Impact factor: 5.157

3.  Histone demethylase KDM5A is transactivated by the transcription factor C/EBPβ and promotes preadipocyte differentiation by inhibiting Wnt/β-catenin signaling.

Authors:  Liang Guo; Ying-Ying Guo; Bai-Yu Li; Wan-Qiu Peng; Qi-Qun Tang
Journal:  J Biol Chem       Date:  2019-05-06       Impact factor: 5.157

4.  ATM mediates pRB function to control DNMT1 protein stability and DNA methylation.

Authors:  Awad Shamma; Misa Suzuki; Naoyuki Hayashi; Masahiko Kobayashi; Nobunari Sasaki; Takumi Nishiuchi; Yuichiro Doki; Takahiro Okamoto; Susumu Kohno; Hayato Muranaka; Shunsuke Kitajima; Ken-Ichi Yamamoto; Chiaki Takahashi
Journal:  Mol Cell Biol       Date:  2013-06-10       Impact factor: 4.272

5.  Selective targeting of histone methylation.

Authors:  Abul B M M K Islam; William F Richter; Nuria Lopez-Bigas; Elizaveta V Benevolenskaya
Journal:  Cell Cycle       Date:  2011-02-01       Impact factor: 4.534

6.  Loss of dE2F compromises mitochondrial function.

Authors:  Aaron M Ambrus; Abul B M M K Islam; Katherine B Holmes; Nam Sung Moon; Nuria Lopez-Bigas; Elizaveta V Benevolenskaya; Maxim V Frolov
Journal:  Dev Cell       Date:  2013-11-25       Impact factor: 12.270

7.  KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.

Authors:  Alexandros Tzatsos; Polina Paskaleva; Francesco Ferrari; Vikram Deshpande; Svetlana Stoykova; Gianmarco Contino; Kwok-Kin Wong; Fei Lan; Patrick Trojer; Peter J Park; Nabeel Bardeesy
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

8.  Coordinated repression of cell cycle genes by KDM5A and E2F4 during differentiation.

Authors:  Michael L Beshiri; Katherine B Holmes; William F Richter; Samuel Hess; Abul B M M K Islam; Qin Yan; Lydia Plante; Larisa Litovchick; Nicolas Gévry; Nuria Lopez-Bigas; William G Kaelin; Elizaveta V Benevolenskaya
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-23       Impact factor: 11.205

9.  JARID1a Ablation in the Liver Alters Systemic Metabolism and Adaptation to Feeding.

Authors:  Kacee Ann DiTacchio; Diana Kalinowska; Anand Rajamani Saran; Ashley Byrne; Christopher Vollmers; Luciano DiTacchio
Journal:  Cell Rep       Date:  2020-05-26       Impact factor: 9.423

10.  JARID1B is a luminal lineage-driving oncogene in breast cancer.

Authors:  Shoji Yamamoto; Zhenhua Wu; Hege G Russnes; Shinji Takagi; Guillermo Peluffo; Charles Vaske; Xi Zhao; Hans Kristian Moen Vollan; Reo Maruyama; Muhammad B Ekram; Hanfei Sun; Jee Hyun Kim; Kristopher Carver; Mattia Zucca; Jianxing Feng; Vanessa Almendro; Marina Bessarabova; Oscar M Rueda; Yuri Nikolsky; Carlos Caldas; X Shirley Liu; Kornelia Polyak
Journal:  Cancer Cell       Date:  2014-06-16       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.